Neoadjuvant ICI Without Chemotherapy Demonstrates Potential Efficacy in Patients with Early-Stage TNBC By Ogkologos - November 21, 2024 745 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BELLINI study Source RELATED ARTICLESMORE FROM AUTHOR The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights of Patients with Cancer via Cross-Border Best Practices and Collaboration Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer ESMO Welcomes Launch of Health Package Introducing EU Measures That Can Boost Innovation in Oncology and Help Prevent New Cancer Cases MOST POPULAR Longest Follow-Up of CAR T-Cell Therapy in Mantle Cell Lymphoma Points... June 14, 2022 FDA Grants Traditional Approval to Selpercatinib for RET Fusion-positive Thyroid Cancer July 2, 2024 Cancer “Liquid Biopsy” Blood Test Gets Expanded FDA Approval November 30, 2020 “My Heart Will Always Hurt”: How I Honor My Childhood Best... April 26, 2022 Load more HOT NEWS Breaking the silence: when cancer steals your voice Stiff “Hot Spots” Within Tumors Help Doctors Predict Spread of Breast... Longer PFS in Patients with Advanced Melanoma Treated with TILs than... BRAF Inhibitor and Rituximab for the Management of Refractory or Relapsed...
